Brief: Artelo Biosciences Announces New Data From An Initial Food Effect Investigation With ART26.12
25/08/2025 13:29
Aug 25 (Reuters) - Artelo Biosciences Inc ARTL.O: ARTELO BIOSCIENCES ANNOUNCES NEW DATA FROM AN INITIAL FOOD EFFECT INVESTIGATION WITH ART26.12, A NOVEL NON-OPIOID TREATMENT CANDIDATE FOR PERSISTENT PAIN ARTELO BIOSCIENCES INC - NO SERIOUS ADVERSE EVENTS IDENTIFIED IN ART26.12 STUDY ARTELO BIOSCIENCES INC - MAD STUDY FOR ART26.12 TO COMMENCE IN Q4 THIS YEAR Source text: ID:nGNX8JFyqM Further company coverage: ARTL.O ((Reuters.Briefs@thomsonreuters.com;))